PRESS RELEASE published on 07/01/2026 at 17:45, 2 months 10 days ago Informations privilégiées / Autres communiqués Advicenne renouvelle l'Autorisation de Mise sur le Marché de Sibnayal® au Royaume-Uni pour le traitement de l'Acidose Tubulaire Rénale distale. Le programme réglementaire est en expansion avec des AMM obtenues notamment dans les pays du Golfe Autorisation De Mise Sur Le Marché Advicenne AMM Sibnayal® Acidose Tubulaire Rénale Distale
BRIEF published on 06/22/2026 at 19:12, 2 months 19 days ago Advicenne Secures Financing to Q2 2027 with New Bond Issue Strategic Development Bond Financing FDA Registration Advicenne Rare Kidney Diseases
BRIEF published on 06/22/2026 at 19:12, 2 months 19 days ago Advicenne obtient un financement jusqu'au deuxième trimestre 2027 grâce à une nouvelle émission obligataire. Développement Stratégique Enregistrement Auprès De La FDA Advicenne Maladies Rénales Rares Financement Par Obligations
PRESS RELEASE published on 06/22/2026 at 19:07, 2 months 19 days ago Informations privilégiées / Autres communiqués Advicenne obtient un financement obligataire de 3,8 millions d'euros pour sécuriser sa trésorerie jusqu'en 2027. Le financement permet la finalisation de l'enregistrement de son produit ADV7103 par la FDA américaine FDA Trésorerie Financement Obligataire Advicenne ADV7103
PRESS RELEASE published on 06/22/2026 at 19:07, 2 months 19 days ago Inside Information / Other news releases Advicenne secures €3.8 million bond financing, extending cash runway to Q2 2027, for FDA registration of ADV7103 in the USA Bond Financing FDA Registration Advicenne Cash Runway ADV7103
BRIEF published on 06/01/2026 at 07:50, 3 months 11 days ago Advicenne receives reimbursement for Likozam® and reduces its debt Advicenna Refund Likozam Debt Reduced Discounts Early Access
BRIEF published on 06/01/2026 at 07:50, 3 months 11 days ago Advicenne obtient le remboursement de Likozam® et réduit sa dette Remboursement Advicenne Likozam Dette Réduite Remises Accès Précoce
PRESS RELEASE published on 06/01/2026 at 07:45, 3 months 11 days ago Informations privilégiées / Autres communiqués Advicenne obtient le remboursement de Likozam® en France, réduisant son endettement de 6 millions d’euros. Likozam® est désormais remboursé aux assurés sociaux, mettant fin aux remises 'Accès précoce' Endettement Remboursement Advicenne Accès Précoce Likozam
BRIEF published on 05/21/2026 at 21:07, 3 months 21 days ago Advicenne Announces Governance Changes Post-AGM Annual General Meeting Financial Restructuring Board Appointments Governance Changes Advicenne
BRIEF published on 05/21/2026 at 21:07, 3 months 21 days ago Advicenne annonce des changements de gouvernance après son assemblée générale annuelle Restructuration Financière Assemblée Générale Annuelle Nominations Au Conseil D'administration Advicenne Changements De Gouvernance
Published on 09/12/2026 at 02:35, 11 hours 18 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 53 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 48 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 28 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 53 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours 23 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 38 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 43 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 18 hours 8 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 38 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
